e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety and efficacy of inhaled mannitol as a bronchial provocation test in children
I. Vasilopoulou, M. Anthracopoulos (Patras, Greece)
Source:
Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Session:
Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Session type:
Thematic Poster Session
Number:
4038
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Vasilopoulou, M. Anthracopoulos (Patras, Greece). Safety and efficacy of inhaled mannitol as a bronchial provocation test in children. Eur Respir J 2011; 38: Suppl. 55, 4038
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The safety and feasibility of the inhaled mannitol challenge test in young children
Source: Eur Respir J 2013; 42: 1420-1423
Year: 2013
Cough provocation test by capsaicin inhalation and its safety in Chinese people
Source: Eur Respir J 2005; 26: Suppl. 49, 301s
Year: 2005
Effect of antileukotriene therapy on methacholine challenge test in patients with mild asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
Efficacy of symbicort administration in patients with bronchial asthma
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Comparison of validity of methacholine and mannitol bronchial challenges in asthma diagnosis
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
Safety of inhaled corticosteroids reduction in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006
Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005
Bronchial provocation tests with dry powder mannitol versus histamine: value for clinical practice and relation to eNO
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009
Bronchial effects of formaldehyde on inhaled allergenic challenge in patients with intermittent asthma
Source: Annual Congress 2005 - Cleaning and cooking: a risk for occupational and household asthma
Year: 2005
Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006
High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
Airway hyperresponsiveness in asymptomatic subjects: is bronchial provocation with mannitol a more specific test?
Source: Eur Respir J 2005; 26: Suppl. 49, 228s
Year: 2005
Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012
Comparative study of bronchial provocation tests using methacholine or mannitol in bronchial asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Assessment of bronchoprovocation test positivity and response to montelukast theraphy in chronic urticaria patients
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Tolerance test for inhaled antibiotics in patients with chronic bronchial infection
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Diagnostic performance of the weight-corrected methacholine bronchial challenge test in children
Source: Eur Respir J 2002; 20: Suppl. 38, 172s
Year: 2002
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
Safety, efficacy and pharmacokinetics of inhaled TPI 1020 in smokers with asthma
Source: Annual Congress 2008 - New treatments for asthma
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept